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Abstract
Introduction: Hyperoxia has recently been reported as an independent risk factor for mortality in patients
resuscitated from cardiac arrest. We examined the independent relationship between hyperoxia and outcomes in
such patients.
Methods: We divided patients resuscitated from nontraumatic cardiac arrest from 125 intensive care units (ICUs)
into three groups according to worst PaO2 level or alveolar-arterial O2 gradient in the first 24 hours after admission.
We defined ‘hyperoxia’ as PaO2 of 300 mmHg or greater, ‘hypoxia/poor O2 transfer’ as either PaO2 < 60 mmHg or
ratio of PaO2 to fraction of inspired oxygen (FiO2 ) < 300, ‘normoxia’ as any value between hypoxia and hyperoxia
and ‘isolated hypoxemia’ as PaO2 < 60 mmHg regardless of FiO2. Mortality at hospital discharge was the main
outcome measure.
Results: Of 12,108 total patients, 1,285 (10.6%) had hyperoxia, 8,904 (73.5%) had hypoxia/poor O2 transfer, 1,919
(15.9%) had normoxia and 1,168 (9.7%) had isolated hypoxemia (PaO2 < 60 mmHg). The hyperoxia group had
higher mortality (754 (59%) of 1,285 patients; 95% confidence interval (95% CI), 56% to 61%) than the normoxia
group (911 (47%) of 1,919 patients; 95% CI, 45% to 50%) with a proportional difference of 11% (95% CI, 8% to
15%), but not higher than the hypoxia group (5,303 (60%) of 8,904 patients; 95% CI, 59% to 61%). In a multivariable
model controlling for some potential confounders, including illness severity, hyperoxia had an odds ratio for
hospital death of 1.2 (95% CI, 1.1 to 1.6). However, once we applied Cox proportional hazards modelling of survival,
sensitivity analyses using deciles of hypoxemia, time period matching and hyperoxia defined as PaO2 > 400
mmHg, hyperoxia had no independent association with mortality. Importantly, after adjustment for FiO2 and the
relevant covariates, PaO2 was no longer predictive of hospital mortality (P = 0.21).
Conclusions: Among patients admitted to the ICU after cardiac arrest, hyperoxia did not have a robust or
consistently reproducible association with mortality. We urge caution in implementing policies of deliberate
decreases in FiO2 in these patients.
Introduction
The majority of patients who experience cardiac arrest
die at the time of the event [1,2]. Even after response to
resuscitation efforts and survival to intensive care unit
(ICU) admission, such patients have a short-term mor-
tality of approximately 60% [1,2]. These dismal out-
comes suggest the need for strategies to attenuate
postresuscitation injury. Such injury is currently mostly
attributed to cerebral, myocardial and global ischemia-
reperfusion injury [3]. Accordingly, postresuscitation
therapy has focused on finding ways to diminish the
intensity and consequences of ischemia-reperfusion
injury.
The rapid application of therapeutic hypothermia can
modify the outcomes of patients after resuscitation from
cardiac arrest [4,5]. The success associated with this inter-
vention suggests that other aspects of patient care, which
may influence the course of reperfusion injury, should also
be logical targets for therapeutic manipulation.
In pursuit of potential therapeutic targets, investigators
from the Emergency Medicine Shock Research Network
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any medium, provided the original work is properly cited.(EMShockNet) recently explored the association between
hyperoxia and in-hospital outcome in a retrospective,
multicentre study [6]. They found that hyperoxia
o c c u r r e di na l m o s to n e - f i f t hof patients, that patients
with hyperoxia had greater in-hospital mortality than
patients with normoxia or hypoxia and that, after con-
trolling for some confounders, hyperoxia carried a clear
independent association with mortality (odds ratio (OR),
1.8). Unfortunately, these investigators used only the first
set of arterial blood gases in the ICU to assess oxygena-
tion, excluded close to 30% of patients because of lack of
arterial blood gas data and did not adjust for standard ill-
ness severity scores. Their conclusion that hyperoxia is a
robust predictor of mortality in patients after resuscita-
tion form cardiac arrest was therefore potentially affected
by selection bias and by insufficient adjustment for major
confounders. Thus, their results are of uncertain signifi-
cance and require confirmation.
The Australian and New Zealand (ANZ) Adult Patient
Database (ANZ-APD) is a high-quality database [7] of
all admissions to most Australian and New Zealand
ICUs. Patients admitted after resuscitation from non-
traumatic cardiac arrest are coded as such. The database
r e c o r d sc o n t a i nA c u t eP h y s i o l o g ya n dC h r o n i cH e a l t h
Evaluation II (APACHE II) and APACHE III scores as
well as demographic, diagnostic and outcome factors
[8]. Given the potential clinical importance of hyperoxia
following cardiac arrest, we used this larger and more
detailed database specifically to confirm or refute the
initial findings of the EMShockNet investigators [6].
Materials and methods
We extracted data from the ANZ Intensive Care Society
(ANZICS)-APD. We used exactly same inclusion criteria
as the EMShockNet investigators [6] for patients
admitted at a participating centre between 2000 and
2009 after resuscitation from an out-of-hospital or in-
hospital cardiac arrest. We excluded readmissions and
patients for whom arterial blood gas analysis or vital sta-
tus at discharge was not available. The ANZICS Centre
for Outcomes and Resource Evaluation (CORE) Man-
agement Committee granted us access to the data in
accordance with standing protocols. Data were collected
under the Quality Assurance Legislation of the Com-
monwealth of Australia (Part VC Health Insurance Act
1973, Commonwealth of Australia) with government
support and funding. Each hospital gives ethics approval
and allows the data to be used for appropriate research,
which is governed by the ANZICS CORE terms of refer-
ence and waives the need for informed consent.
Data collection for oxygen values
All arterial blood gases during the first 24 hours of ICU
admission were collected and entered into a standardized
data collection system which automatically selects the
appropriate high and low simultaneous fraction of
inspired oxygen (FiO2) and partial pressure of arterial
oxygen (PaO2) measurements and deletes other oxygena-
tion data. Using the APACHE II and III methodology for
intubated patients with FiO2 ≥0.5, the PaO2 associated
with the arterial blood gas with the highest alveolar-arter-
ial (A-a) gradient is selected as the index of worst oxyge-
nation. For nonintubated patients or intubated patients
with FiO2 < 0.5, the lowest arterial blood gas PaO2 level
is recorded. The ratio of PaO2 to FiO2 (P/F ratio) is also
used as an index of illness severity.
Data extraction
We recorded the sizes, types and locations of the hospi-
tals. At the patient level, we extracted the following vari-
ables: demographics, comorbidities according to
APACHE II and III classifications, hospital and ICU
admission source, intubation, treatment limitation, year
of admission, physiological and arterial blood gas para-
meters over the first 24 hours in the ICU, vital status at
hospital discharge, hospital discharge destination and an
APACHE III risk of death score [8]. As a marker of
severity of illness independent of arterial oxygenation,
we calculated an adjusted APACHE III index of illness
severity (AP3no-ox), in which the oxygen component of
the APACHE III scoring system was removed.
Statistical analyses
All analyses were performed using SAS version 9.2 (SAS
Institute Inc., Cary, NC, USA). Continuous data are pre-
sented as means ± standard deviations or as medians
with interquartile ranges (IQRs), depending on the
underlying data distribution. Categorical data are
reported as proportions. We categorized oxygenation
levels into the same three groups as in the EMShockNet
study [6], defined by the worst PaO2 and P/F ratio
obtained in the first 24 hours of ICU admission. Thus,
we divided patients into three groups according to worst
PaO2 or A-a O2 gradient in the first 24 hours after
admission. We defined ‘hyperoxia’ as a PaO2 300 mmHg
or greater, ‘hypoxia/poor O2 transfer’ as either PaO2 <
60 mmHg or a P/F ratio <300, ‘normoxia’ as any value
between hypoxia and hyperoxia and ‘isolated hypoxemia’
as PaO2 < 60 mmHg regardless of FiO2 level.
The primary outcome measures were in-hospital mor-
tality and survival time, which are reported as ORs (95%
confidence interval (95% CI)) or hazard ratios (HRs)
(95% CI), respectively. To determine functional recovery,
we also considered discharge to home as a secondary
outcome. We compared outcomes between groups
using the c
2 test with the Bonferroni correction. We
conducted multivariate analysis using logistic regression
for mortality and Cox proportional hazards regression
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stepwise selection and backwards elimination proce-
dures. To increase robustness and model validity, we
used a P value of 0.01 for variable inclusion. We applied
several models to the statistical analysis of the indepen-
dent relationship between oxygenation and patient out-
come. We constructed an initial model for mortality in
accordance with the EMShockNet model (see Additional
file 1, Statistical appendix, Model 1) [8]. We then
applied a second model to improve discriminatory
power using AP3no-ox as a marker of severity (see
Additional file 1, Statistical appendix, Model cluster 2).
Finally, we conducted further sensitivity analysis inclu-
sive of propensity analysis [9], Cox proportional hazards
modelling, testing of different cutoff points for hyper-
oxia, analysis of subgroups contemporaneous with the
EMShockNet cohort and assessment of PaO2 according
to deciles (Additional file 1, Statistical appendix, Model
cluster 3).
As our database contained only the worst recorded
oxygenation in the first 24 hours after ICU admission,
we explored its relationship with that of the first PaO2
measurement after ICU admission (as in the EMShock-
Net study) and the mean oxygenation on ICU admission
days 1, 2 and 3 by selecting 100 of the database patients
and obtaining additional data from all of their hospital
arterial blood gas records during their ICU stay (see
Additional file 1, Statistical appendix, Model cluster 3).
Statistical power considerations
The proportion of living patients with hyperoxia (PaO2
> 400) was 5% (n = 280). Comprising 5,140 patients
who lived and 6,968 patients who died, this study had
93% power to detect a change of 1.5% (5% versus 6.5%)
in the proportion of patients with hyperoxia (PaO2 >
400) with a two-sided P value of 0.05.
There were 625 patients in the data set with hyperoxia
(PaO2 > 400). Comprising 11,483 patients without
hyperoxia, this study had 90% power to detect a differ-
ence in mortality of 7% (55% versus 62%) between
groups with a two-sided P value of 0.05. Given an
observed difference of 14% (55% versus 69%) in the
EMShockNet study between hyperoxic patients (PaO2 >
400) and nonhyperoxic patients, we felt that this study
was adequately powered to detect a relationship between
mortality and PaO2 > 400. In our study, the mortality
rate in the hyperoxia group (PaO2 > 400) was only 0.5%
higher than that in the nonhyperoxia group (54.7% ver-
sus 55.2%, P = 0.22).
There were 531 hyperoxia survivors (PaO2 > 300). With
4,609 nonhyperoxia survivors, this study had 80% power
to detect a difference between groups of 6% (64% versus
58%) regarding the proportion discharged to home with a
two-sided P value of 0.05. Given an observed difference of
6% (38% versus 44%) in the EMShockNet study between
hyperoxic survivors (PaO2 > 300) discharged to home and
discharged nonhyperoxic survivors, we again felt that this
study was adequately powered to detect a relationship
between hyperoxia and discharge to home. In our study,
there was no observed difference in the proportion of
patients who were discharged to home between the hyper-
oxia and nonhyperoxia groups.
Results
There were 12,806 patients who met the study inclusion
criteria. Of these, 698 (5.4%) were excluded: 222 (1.7%)
had missing arterial blood gas data, 382 (3.0%) had
missing hospital mortality data and 94 (0.7%) were ICU
readmissions. The remaining 12,108 patients were
drawn from among 125 contributing ICUs. The median
number of cardiac arrest cases per hospital was 42 (IQR,
13-148). Baseline characteristics for all groups are given
in Tables 1 and 2.
The average age of patients was 64 years (SD ± 16),
and 64% (7,802) were male. A total of 8,175 patients
( 6 8 % )w e r ea th o m ep r i o rt ohospital admission and
5,756 patients (48%) were admitted to the ICU directly
from the Emergency Department. One-third (3,978) of
the patients had preexisting chronic comorbidities. The
median APACHE III risk of death was 66% (IQR, 36%-
84%). Most patients (8,904, 73.5%) had ‘hypoxia/poor O2
transfer’, while 1,285 (10.6%) were hyperoxic and 1,919
(15.9%) were normoxic. Isolated hypoxemia (PaO2 <6 0
mmHg) was present in 1,168 patients (9.7%).
There were no significant differences in the measured
physiological data between the three main oxygenation
groups (Table 3). Patients had a median lowest tempera-
ture of 34.9°C, and in 33% of the patients, this value was
below 34.0°C. The median ICU length of stay for survi-
vors from ICU admission to hospital discharge was 3.8
days (IQR, 2.0 to 7.1), and for nonsurvivors it was 1.5
days (IQR, 0.5 to 3.3). The median length of hospital
stay for survivors was 14.9 days (IQR, 8.2 to 27.2), and
for nonsurvivors it was 3.4 days (IQR, 1.5 to 8.1).
Overall, 6,968 patients (58%) died in the hospital
(Table 4). Mortality was significantly lower (P <0 . 0 0 0 1 )
in the normoxia group than in either the hyperoxia
group or the hypoxia/poor O2 transfer group. It was
highest, however, in patients with ‘isolated hypoxemia’
(812 (70%) of 1,168 patients, P < 0.0001). The propor-
tion of patients discharged directly to home was signifi-
cantly higher in the normoxia group than in the other
groups. The lowest rate of discharge to home was in
patients with isolated hypoxemia (222 (19%) of 1,168
patients, P < 0.0001). Overall, 65% of survivors were dis-
charged directly to home.
When the EMShockNet statistical model was repli-
cated, 12 risk factors were significantly associated with
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the model (Hosmer-Lemeshow goodness-of-fit test, P =
0.71), and the area under the curve (AUC) was 0.72.
Hypoxia/poor O2 transfer or hyperoxia were signifi-
cantly associated with an increased risk of mortality in
comparison to normoxia (OR 1.4 (95% CI, 1.3 to 1.6), P
< 0.0001, and OR 1.5 (95% CI, 1.3 to 1.8), P < 0.0001,
respectively). Once illness severity was added to the
model (Table 6) (Additional file 1, Statistical appendix,
Model cluster 2), the magnitude of the effect size was
markedly lower than in the original EMShockNet model
(hypoxia versus normoxia: OR 1.2 (95% CI, 1.1 to 1.4),
P = 0.002; hyperoxia versus normoxia: OR 1.2 (95% CI,
1.0 to 1.5), P = 0.04). This APACHE-based model
showed improved discriminatory power in comparison
to the EMShockNet model (AUC 0.79 when AP3no-ox
was applied in isolation versus AUC 0.81 when AP3no-
ox was applied in combination with other variables
listed in Table 6). Data were well fitted by the model
(Hosmer-Lemeshow goodness-of-fit test, P = 0.42).
Table 1 Baseline characteristics of the study patients
a
Patient characteristics All patients
(N = 12,108)
Hypoxia/poor
O2 exchange
(n = 8,904)
Normoxia
(n = 1,919)
Hyperoxia
(n = 1,285)
Mean age, yr (±SD) 64 (16) 64 (16) 62 (18) 65 (17)
Male sex, n (%) 7,802 (64) 5,778 (65) 1,228 (64) 796 (62)
Indigenous Australians, n (%) 515 (5) 388 (5) 74 (4) 53 (4)
Hospital admission source from home, n (%) 8,175 (68) 5,986 (67) 1,273 (66) 916 (71)
Acute renal failure, n (%) 2,368 (20) 1,916 (22) 237 (12) 215 (17)
Chronic comorbidities, n (%)
Cardiovascular disease, n (%) 2,395 (20) 1,821 (20) 357 (19) 217 (17)
Liver disease, n (%) 194 (2) 158 (2) 17 (1) 19 (1)
Renal disease, n (%) 668 (6) 488 (5) 100 (5) 80 (6)
Respiratory disease, n (%) 1,044 (9) 831 (9) 102 (5) 111 (9)
Cirrhosis, n (%) 195 (2) 158 (2) 18 (1) 19 (1)
Hepatic failure, n (%) 70 (1) 52 (1) 10 (1) 8 (1)
Immune suppression, n (%) 329 (3) 243 (3) 41 (2) 45 (4)
Cancer, n (%) 413 (3) 320 (4) 48 (3) 45 (4)
Markers of severity
Median APACHE III risk of death (IQR) 66% (36 to 84) 69% (40 to 86) 50% (20 to 73) 66% (36 to 84)
Median APACHE III risk of death (no oxygen)
b (IQR) 58% (27 to 79) 60% (29 to 80) 47% (18 to 71) 58% (29 to 80)
ICU admission source, n (%)
Emergency department 5,756 (48) 4,123 (46) 1,035 (54) 598 (47)
Operating theatre 1,261 (10) 925 (10) 217 (11) 119 (9)
Other hospital 1,958 (16) 1,445 (16) 319 (17) 194 (15)
Ward 3,113 (26) 2,397 (27) 344 (18) 372 (29)
Treatment limitation
c 562 (5) 429 (5) 68 (4) 65 (5)
aAPACHE III, Acute Illness Severity and Chronic Health Evaluation III; IQR, interquartile range; ICU, intensive care unit;
bAPACHE III risk of death with oxygen
component removed from APACHE III score;
ctreatment limitation order or coded for palliative care.
Table 2 Baseline characteristics of the study hospitals
Hospital characteristics, n (%) All patients
(N = 12,108)
Hypoxia/poor O2 exchange
(n = 8,904)
Normoxia
(n = 1,919)
Hyperoxia
(n = 1,285)
Hospital size
a
Small to medium (≤300 beds) 2,475 (20) 1,813 (20) 361 (19) 301 (23)
Large (301 to 500 beds) 5,277 (44) 3,906 (44) 843 (44) 528 (41)
Extra large (>500 beds) 4,356 (36) 3,185 (36) 715 (37) 456 (35)
Hospital type and location
Metropolitan community 2,670 (22) 1,988 (22) 437 (23) 245 (19)
Private 787 (6) 573 (6) 89 (5) 125 (10)
Rural 1,279 (11) 939 (11) 205 (11) 135 (11)
Tertiary academic 7,372 (61) 5,404 (61) 1,188 (62) 780 (61)
aDefined according to Halpern et al. [30].
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appendix, Model cluster 3) did not alter this risk or the sig-
nificance of hyperoxia. However, when the secondary out-
come of discharge to home was considered, oxygenation
status was no longer a statistically significant predictor (P =
0.64). Using a Cox proportional hazards regression model,
we found both hyperoxia and hypoxia/poor O2 transfer to
increase the hazard of death in comparison to the nor-
moxia group (HR 1.3 (95% CI, 1.1 to 1.4), P <0 . 0 0 1 ,a n d
HR 1.3 (95% CI, 1.2 to 1.4), P < 0.0001, respectively). After
adjustment for the covariates described in Additional file 1,
Statistical appendix, Model cluster 2, however, oxygenation
status was no longer statistically significant (hyperoxia: OR
1.1 (95% CI, 1.0 to 1.2), P = 0.20; hypoxia: OR 1.1 (95% CI,
1.0 to 1.2), P = 0.01) (Table 6).
When a PaO2 of 200 mmHg or greater was used to
define hyperoxia, after adjustment (Additional file 1, Sta-
tistical appendix, Model cluster 2), oxygenation status
was a statistically significant predictor of outcome (P =
0.002) (hyperoxia: OR 1.3 (95% CI, 1.1 to 1.5), P =0 . 0 1 ;
hypoxia: OR 1.3 (95% CI, 1.1 to 1.5), P = 0.001). When
aP a O 2 of 400 mmHg or greater was used in sensitivity
analysis after adjustment, however (Additional file 1,
Statistical appendix, Model cluster 2), oxygenation status
was no longer statistically significant (P = 0.06) (hyper-
oxia: OR 1.0 (95% CI, 0.8 to 1.2), P = 0.71; hypoxia: OR
1.1 (95% CI, 1.0 to 1.3), P = 0.04).
When PaO2 was divided into deciles and modelled as a
predictor of hospital mortality, it was statistically
significant at a univariate level (P < 0.0001), but with only
the lowest two deciles having ORs significantly greater
than the norm (Figure 1). After adjustment for FiO2 and
the covariates described in Additional file 1, Statistical
appendix, Model cluster 2, PaO2 was no longer predictive
of hospital mortality (P = 0.21), although those patients
with isolated hypoxemia (PaO2 < 60 mmHg) had a signif-
icantly greater risk (OR 1.2 (95% CI, 1.0 to 1.5), P = 0.03)
(Figure 1). Importantly, 492 patients (42.1%) with isolated
hypoxemia were receiving deliberate decreases of FiO2 to
<0.8 at the time of their hypoxemia. There was no statis-
tical evidence that patients with higher PaO2 levels had
significantly greater risk of hospital mortality.
When the corresponding time period used by the
EMShockNet study group [6] (2001 to 2005) was consid-
ered, after adjustment (Additional file 1, Statistical appen-
dix, Model cluster 2), oxygenation was not predictive of
mortality (P = 0.16) (hyperoxia: OR 1.3 (95% CI, 0.9 to
1.8), P = 0.16; hypoxia: OR 1.3 (95% CI, 1.0 to 1.6), P =
0.06). When more detailed information was obtained from
a random sample of 100 patients, the worst PaO2 value
over the first 24 hours was significantly more representa-
tive of mean PaO2 than the first PaO2 value measured
upon admission used by the EMShockNet study group [6].
This was true for the first 24 hours (Pearson’s r = 0.70 ver-
sus Pearson’s r = 0.50, P < 0.0001), the first 48 hours
(Pearson’s r = 0.63 versus Pearson’s r =0 . 3 8 ,P < 0.0001)
and the first 72 hours (Pearson’s r = 0.60 versus Pearson’s
r =0 . 3 4 ,P < 0.0001).
Table 3 Abnormal vital signs in the first 24 hours in intensive care unit and interventions
Vital signs (means ± SD) All patients
(N = 12,108)
Hypoxia/poor O2 exchange
(n = 8,904)
Normoxia
(n = 1,919)
Hyperoxia
(n = 1,285)
Highest body temperature 37.1°C (1.5) 37.1°C (1.5) 37.1°C (1.4) 37.1°C (1.5)
Lowest body temperature 34.9°C (1.7) 34.9°C (1.7) 34.8°C (1.8) 34.7°C (1.7)
Highest heart rate, beats/min 108 (28) 109 (28) 104 (26) 108 (28)
Highest respiratory rate, breaths/min 22.0 (9.0) 22.2 (9.0) 21.4 (9.2) 21.4 (9.0)
Lowest systolic blood pressure, mmHg 88.6 (25.1) 87.3 (25.0) 94.1 (22.8) 88.9 (27.2)
Lowest mean arterial pressure, mmHg 62.3 (16.0) 61.5 (15.8) 66.2 (14.5) 62.5 (18.0)
Lowest glucose level first 24 hours 6.9 (3.9) 6.9 (4.0) 6.4 (3.1) 6.9 (3.6)
Body temperature, n (%)
Highest temperature <34°C 860 (7) 639 (7) 90 (5) 131 (10)
Lowest temperature <34°C 4031 (33) 2918 (33) 659 (34) 454 (35)
Table 4 Outcomes of study patients
Patient outcomes All patients
(N = 12,108)
Hypoxia/poor O2 exchange
(n = 8,904)
Normoxia
(n = 1,919)
Hyperoxia
(n = 1,285)
In-hospital mortality
a, n (%) (95% CI) 6,968 (58) (57 to 58) 5,303 (60) (59 to 61) 911 (47) (45 to 50) 754 (59) (56 to 61)
Discharge destination for survivors, n 5,140 3,601 1,008 531
Home
a, n (%) (95% CI) 3,341 (28) (27 to 28) 2,350 (26) (25 to 27) 649 (34) (32 to 36) 342 (27) (24 to 29)
Rehabilitation facility 655 (5) 447 (5) 118 (6) 90 (7)
Transfer to another hospital 1,144 (9) 804 (9) 241 (13) 99 (8)
aP < 0.0001 for comparisons of normoxia with hyperoxia and normoxia with hypoxia in patients discharged to home.
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Key findings
We conducted a large, multicentre, cohort study of
patients admitted to ICUs in ANZ after resuscitation
from cardiac arrest to examine the relationship between
hyperoxia and patient outcome. We initially found that
hyperoxia was relatively uncommon and had only a
weak relationship with risk of death. This relationship
was significantly reduced by the addition of illness
severity scores. In addition, once Cox proportional
hazards modelling of survival, sensitivity analyses using
deciles of hypoxemia, time period matching and defining
hyperoxia in keeping with experimental studies [10-13]
as PaO2 > 400 mmHg, hyperoxia had no independent
association with mortality. Finally, after adjustment for
FiO2 and relevant covariates, PaO2 was no longer pre-
dictive of hospital mortality. Thus, hyperoxia was rela-
tively uncommon, and it had no robust and consistently
reproducible independent relationship with mortality.
Comparison with other studies
Until very recently, concerns about the possible risks
associated with hyperoxia during and after recovery from
cardiac arrest were based on animal experiments [10-13].
In this regard, several experimental studies have sug-
gested that hyperoxia can increase oxidative stress [14],
induce more severe histopathological changes [10] and
worsen neurological injury [15]. On the other hand, two
studies have failed to confirm such findings [16,17], and
two other often-quoted major studies did not actually
assess animals after cardiac arrest [10,12]. Nonetheless,
despite the lack of human data, the International Liaison
Committee on Resuscitation moved to advocate the
avoidance of arterial hyperoxia. The committee instead
advocated the targeting of arterial oxygen saturation not
exceeding 94% to 96% [18]. In response to these issues,
in June 2010, the EMShockNet investigators reported
that, in a cohort of 6,326 USA patients who had survived
nontraumatic cardiac arrest and were admitted to the
ICU, hyperoxia was independently associated with
increased risk (OR 1.6) of in-hospital mortality. This was
the largest clinical study to date of the association
between hyperoxia after cardiac arrest and mortality. Our
findings should therefore be evaluated in direct compari-
son to the EMShockNet study and have been specifically
configured to facilitate such comparison.
Several important observations emerge from such
comparison. First, the baseline characteristics of the U.S.
and ANZ patients appear almost identical, although no
information was available on the APACHE scores for
Table 5 Multiple logistic regression model with in-
hospital mortality as dependent variable using
EMShockNet model variables
a
Variable OR (95%CI) P value
Acute renal failure 3.3 (2.9 to 3.7) <0.0001
Hypotension in first 24 hours
b 1.9 (1.7 to 2.0) <0.0001
Age, decile 1.1 (1.1 to 1.1) <0.0001
Emergency department origin 1.6 (1.4 to 1.7) <0.0001
High heart rate
c 1.5 (1.3 to 1.6) <0.0001
Hypoxia/poor O2 exchange versus normoxia 1.4 (1.3 to 1.6) <0.0001
Hyperoxia versus normoxia 1.5 (1.3 to 1.8) <0.0001
Cancer 2.0 (1.5 to 2.5) <0.0001
Cirrhosis 2.2 (1.5 to 3.1) <0.0001
Female sex 1.2 (1.1 to 1.3) <0.0001
Chronic renal 1.4 (1.1 to 1.6) 0.001
Chronic respiratory disease 1.3 (1.1 to 1.5) 0.002
Hepatic failure 2.7 (1.3 to 5.9) 0.01
aEMShockNet, Emergency Medicine Shock Research Network; OR, odds ratio;
95% CI, 95% confidence interval. The following variables (OR (95% CI), P
value) were removed from the model for nonsignificance (P < 0.01):
immunosuppression (1.3 (1.0 to 1.7), P = 0.04), indigenous status (1.2 (0.9 to
1.5), P = 0.13), chronic cardiovascular disease (1.1 (0.9 to 1.2), P = 0.34),
chronic liver disease (0.6 (1.0 to 3.3), P = 0.56) and hospital source prior to
admission being from home (1.0 (0.9 to 1.1), P = 0.61).
bDefined as any
systolic blood pressure of less than 90 mmHg in the first 24 hours;
cindicates
highest value for first 24 hours in the intensive care unit (1 = exceeds median
and 0 = median or lower).
Table 6 Multiple regression models for in-hospital mortality and survival time using an APACHE III-based marker of
severity
a
Variable Hospital mortality
OR (95% CI)
P value Time to death
HR (95% CI)
P value
AP3no-ox
b 1.5 (1.5 to 1.6) <0.0001 1.2 (1.2 to 1.2) <0.0001
Treatment limitation
c 5.3 (3.8 to 7.2) <0.0001 1.7 (1.5 to 1.8) <0.0001
Year of admission 0.9 (0.9 to 0.9) <0.0001 0.97 (0.96 to 0.98) <0.0001
Lowest glucose in first 24 hours 1.1 (1.1 to 1.1) <0.0001 1.02 (1.02 to 1.03) <0.0001
Hospital admission from home 1.3 (1.1 to 1.4) 0.0002 1.1 (1.0 to 1.1) 0.02
Hypoxia/poor O2 exchange versus normoxia 1.2 (1.1 to 1.4) 0.002 1.1 (1.0 to 1.2) 0.01
Hyperoxia versus normoxia 1.2 (1.0 to 1.5) 0.04 1.1 (1.0 to 1.2) 0.20
aAPACHE III, Acute Illness Severity and Chronic Health Evaluation III; OR, odds ratio; 95% CI, 95% confidence interval; HR, hazard ratio; AP3no-ox, APACHE III score
with oxygenation component removed;
bAPACHE III risk of death with oxygen component removed from calculation algorithm;
ctreatment limitation order or
palliative care coded for the patient. Indigenous status was removed from both models for nonsignificance (P < 0.01): (OR 1.3 (95% CI, 1.0 to 1.8), P = 0.04), (HR
1.1 (95% CI, 0.9 to 1.1) P = 0.89).
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striking differences in the lowest body temperatures
recorded (ANZ 34.9°C, USA 36°C). These differences
may reflect greater uptake of therapeutic hypothermia in
ANZ and make the observations from our cohort more
relevant to current recommended practice [4,5]. How-
ever, we cannot determine whether greater use of thera-
peutic hypothermia accounts for the difference in the
proportion of survivors discharged to home (65% in
ANZ as compared to 44% in the USA, approximately a
50% relative increase in favourable outcome).
In the ANZ cohort, hyperoxia occurred in only 10.6%
of patients as compared with 18% in the USA, and mor-
tality in the hyperoxic group was identical to that in the
hypoxia/poor O2 transfer group, instead of being much
greater. Importantly, the relationship between hyperoxia
and in-hospital mortality appeared much weaker using
the same modelling used by the EMShockNet investiga-
tors. Even more importantly, this relationship could not
be confirmed when a different threshold for hyperoxia
was applied which mimicked that reported in experi-
mental studies [11-13] (rather than using a seemingly
arbitrary cutoff point of 300 mmHg), when a Cox pro-
portional hazards model was used, when PaO2 was split
into deciles, when FiO2 was taken into account or when
the same time period (2000 to 2005) was used for analy-
sis. In the aggregate, these observations suggest that the
relationship between hyperoxia and mortality is depen-
dent on the individual healthcare system, the statistical
model used, the time period examined and the defini-
tions used. Such features are not consistent with a
robust and reproducible biological phenomenon.
Study significance
Our findings imply that it is incorrect and premature to
conclude that hyperoxia is an independent risk factor for
mortality in patients resuscitated from nontraumatic car-
diac arrest. In particular, we contend that hyperoxia
implies the administration of high FiO2 fractions, making
it more likely for hyperoxia to actually be a marker of ill-
ness severity than a biological toxin. This notion is sup-
ported by the significant decrease in ORs for mortality
once APACHE scores were added to the model and the
disappearance of significant ORs once FiO2 was added to
the model. Moreover, the definition of ‘hypoxia’ used by
the EMShockNet investigators (reproduced here to facili-
tate comparison under the term ‘hypoxia/poor O2 trans-
fer’) included patients with a P/F ratio <300, together with
patients with PaO2 < 60 mmHg. This approach conflates
physiologically relevant lack of oxygen at the tissue level
(true hypoxia) with a gas transfer problem. When we
examined isolated hypoxemia (PaO2 < 60 mmHg), we
found that it was nearly as frequent as hyperoxia. The
risks of cerebral injury associated with hypoxemia are well
known [19-21], and hypoxemic patients in our cohort had
particularly poor outcomes. Importantly, after adjustment
for FiO2 and relevant covariates, PaO2 was no longer pre-
dictive of hospital mortality. These observations suggest
that the association seen in the models that do not include
FiO2 may simply reflect the fact that hyperoxia is an indir-
ect marker of higher FiO2 (that is, the higher the FiO2, the
greater the PaO2)a n dt h a tah i g h e rF i O 2 is a marker of ill-
ness severity (that is, the sicker the patient is perceived to
be, the greater the FiO2 administered in an emergency
situation). However, the link between FiO2 and outcome is
independent of APACHE score. Thus, FiO2 cannot be
considered simply a marker of disease severity. The physi-
cian can lower PaO2 and FiO2 levels at the same time and
avoid inducing hyperoxia. Only interventional studies can
clarify whether the association between oxygenation and
outcome is truly a causal relationship.
All the above observations have potential clinical rele-
vance. For example, emergency responders may not
have access to pulse oximetry or blood gas analysis, or
such techniques may be unreliable immediately follow-
ing cardiac arrest because of decreased peripheral perfu-
sion. If fear of hyperoxia led emergency responders, in
the absence of adequate monitoring, to limit FiO2 levels,
logically more people wouldl i k e l yb ee x p o s e dt ot h e
risk of hypoxemia. In our study, >40% of patients with
hypoxemia might have had correction of their hypoxe-
mia had a higher FiO2 level been induced. Thus, if con-
cerns about the alleged ill effects of hyperoxia or high
Figure 1 Odds ratios for hospital mortality by deciles of PaO2.
Odds ratios for hospital mortality with partial pressure of arterial
oxygen (PaO2) divided into deciles and referenced against the
fourth decile (PaO2, 83 to 93). The adjusted model included the
following covariates: fraction of inspired oxygen (deciles), Acute
Physiology and Chronic Health Evaluation III (APACHE III) index of
illness severity in which the oxygen component of the APACHE III
scoring system was removed, year of admission, treatment
limitation on admission to intensive care unit, patient’s lowest
glucose level in the first 24 hours, hospital characteristics, patient
indigenous status and hospital source from home. 95% CI, 95%
confidence interval.
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avoid a condition whose association with mortality is
uncertain, more patients might be exposed to a condi-
tion whose adverse cerebral effects are well established.
Given our findings, we counsel against implementing
policies of deliberately induced decreases in FiO2 unless
accurate continuous pulse oximetry monitoring is in
place. Importantly, in no way do we advocate, promote
or justify hyperoxia in this setting. However, lowering
FiO2 is justified only if good transcutaneous or arterial
oxygenation monitoring is available.
Strengths and limitations
This study has several strengths. It involved more than
12,000 patients from 125 ICUs in two countries, making
it the largest study of its type conducted so far and mak-
ing its findings reflective of all ICUs in ANZ [22,23]. It
included a multifaceted assessment of the independent
relationship between hyperoxia and outcome using mul-
tiple models and adjusting for illness severity. However,
like other studies of association using a large database, it
is limited by the nature of the data available and by the
fact that no causal inferences can be drawn. The assess-
ment of oxygenation status in the first 24 hours was
based on the ‘worst’ possible arterial blood gas result,
while the EMShockNet study used the ‘first’ ICU arterial
blood gas measurement for evaluation. Thus, patients
may have been exposed to hyperoxia and may not have
been identified in our study. However, using a random
sample of 100 patients, we found that the measurement
used in our study was more closely representative of
overall mean oxygenation status in ICU patients during
the first 24 to 48 hours after admission (when reperfusion
injury occurs) than the first set of blood gas measure-
ments obtained in the ICU. In our study, data were miss-
ing for only 5.4% of patients compared with 27.6% in the
EM ShockNet study, making selection bias in our study
less likely. One-third of patients had a lowest body tem-
perature <34°C. Clinical knowledge (confirmed by the
EMShockNet data) that such severe spontaneous
hypothermia is uncommon suggests that many patients
were therefore treated with induced hypothermia as is
common in ANZ [24-28]. This finding distinguishes our
study from the US investigation because it is in keeping
with current recommendations. Unfortunately, however,
our database does not enable us to identify which
patients had induced versus spontaneous hypothermia.
Finally, we are unable to comment on the causes of death
or consider other potential confounding variables that
were not collected as part of the ANZICS-APD.
Future studies
More investigations appear necessary, perhaps using
other national databases [29]. Prospective investigations
with focused data collection are also needed. If such stu-
dies confirmed a postive association, interventional stra-
tegies should be tested; if not, interventional studies
would not seem justified.
Conclusions
In a large, multicentre, cohort study of patients admitted
to the ICU after resuscitation from cardiac arrest, we
found that hyperoxia was relatively uncommon. On the
basis of initial multivariable analysis, it had only a weak
independent relationship with mortality. This relation-
ship could not be confirmed on the basis of sensitivity
analysis, adjusted Cox proportional hazards modelling,
after taking FiO2 into account or after adjusting for time
period, making it unlikely that it represents a reproduci-
ble biological phenomenon. Our findings support argu-
ments against implementing policies of deliberate
decreases in FiO2 unless accurate and reliable pulse oxi-
metry monitoring is available.
Key messages
￿ When the worst set of arterial blood gases is used
for assessment, hyperoxia is uncommon in the first
24 hours after ICU admission in patients resusci-
tated from cardiac arrest.
￿ Using the same approach, isolated hypoxemia is
just as common.
￿ Hyperoxia in these patients has a weak, model-
dependent and nonreproducible association with
mortality.
￿ Unless accurate and reliable pulse oximetry is
available to prevent hypoxemia, a policy of reducing
FiO2 to avoid possible hyperoxia is not justified and
may not be prudent.
Additional material
Additional file 1: Statistical appendix with details of multiple
statistical models linking oxygen status with outcome.
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